Switching treatments in haemophilia: Is there a risk of inhibitor development?

Elena Santagostino, Günter Auerswald, Gary Benson, Gerry Dolan, Victor Jiménez-Yuste, Thierry Lambert, Rolf Ljung, Massimo Morfini, Eduardo Remor, Silva Zupančić Šalek

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Switching treatments in haemophilia: Is there a risk of inhibitor development?'. Together they form a unique fingerprint.

Medicine & Life Sciences